| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4092532 | SAS Journal | 2007 | 6 Pages |
Abstract
Development testing has been submitted to the US Food and Drug Administration and permission obtained to initiate an investigational device exemption trial to clinically investigate the efficacy of the Stabilimax NZ device.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Manohar M. PhD, Jens Peter BS,
